Literature DB >> 9276595

Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study.

P W Payne1, T J Sebo, A Doudkine, D Garner, C MacAulay, S Lam, J C LeRichie, B Palcic.   

Abstract

OBJECTIVE: To investigate the hypothesis that image cytometry of sputum specimens can detect squamous carcinoma without requiring visually abnormal cells.
DESIGN: The sensitivity and specificity of image cytometry were evaluated in a case-control study.
MATERIAL AND METHODS: Seventy-three sputum slides from the Mayo portion of the National Cancer Institute Cooperative Early Lung Cancer Study were restained by a modified Feulgen method. We examined 40 slides from 9 patients in whom squamous carcinoma developed and 33 slides from 11 patients in whom no cancer developed during a follow-up of at least 5 years. Images of normal epithelial nuclei were collected by using an automated image cytometer. Discriminant analysis was used to determine differences in DNA distribution of normal nuclei in sputum specimens from noncancer patients versus normal nuclei in sputum samples from patients in whom carcinoma developed.
RESULTS: By using features based on DNA distribution, 74% correct classification of nuclei was possible without human review of the material and without the use of visually abnormal nuclei. A receiver operating characteristic curve demonstrated sensitivities and specificities, including 40% sensitivity and 90% specificity.
CONCLUSION: Although this study was limited to 20-year-old slides and squamous cell carcinoma, automated image cytometry detected a substantial proportion of patients with squamous cell cancer without using visually abnormal nuclei.

Entities:  

Mesh:

Year:  1997        PMID: 9276595     DOI: 10.4065/72.8.697

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  Sputum examination for early detection of lung cancer.

Authors:  F B J M Thunnissen
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial.

Authors:  K Häussinger; H Becker; F Stanzel; A Kreuzer; B Schmidt; J Strausz; S Cavaliere; F Herth; M Kohlhäufl; K-M Müller; R-M Huber; U Pichlmeier; Ch T Bolliger
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

Review 3.  Benefits and harms of CT screening for lung cancer: a systematic review.

Authors:  Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

4.  Detection of DNA aneuploidy in exfoliated airway epithelia cells of sputum specimens by the automated image cytometry and its clinical value in the identification of lung cancer.

Authors:  Jian Yang; Yikai Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 5.  Early detection for lung cancer. New tools for casefinding.

Authors:  S Lam; B Lam; T L Petty
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

Review 6.  New approaches to lung cancer prevention.

Authors:  Annette McWilliams; Stephen Lam
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

7.  Double staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cells.

Authors:  Gerald Li; Martial Guillaud; Michele Follen; Calum MacAulay
Journal:  Anal Quant Cytopathol Histpathol       Date:  2012-10

8.  DNA image cytometric analysis of bronchial washings as an adjunct for the detection of lung cancer in a clinical setting.

Authors:  Yan Hu; Qing Yu; Cuiyan Guo; Guangfa Wang
Journal:  Cancer Med       Date:  2022-02-11       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.